Champlain Investment Partners’s QIAGEN NV QGENF Stock Holding History

Champlain Investment Partners’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-562,705	Closed	-$13.2M	–	146
2014 Q4	$13.2M	Sell	562,705 -526,095	-48%	-$12.3M	0.21%	114
2014 Q3	$24.8M	Sell	1,088,800 -20,840	-2%	-$475K	0.43%	100
2014 Q2	$27.1M	Buy	1,109,640 +47,850	+5%	+$1.17M	0.44%	99
2014 Q1	$22.4M	Buy	1,061,790 +220,180	+26%	+$4.64M	0.39%	106
2013 Q4	$20M	Buy	841,610 +22,525	+3%	+$536K	0.35%	107
2013 Q3	$17.5M	Buy	819,085 +41,900	+5%	+$897K	0.33%	107
2013 Q2	$15.5M	Buy	+777,185	New	+$15.5M	0.31%	117

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Champlain Investment Partners's QGENF Position: Q1 2015 in Review

Champlain Investment Partners sold out of QIAGEN NV (QGENF) in Q1 2015, closing a stake of 562,705 shares — an estimated $13.2M sold.

Champlain Investment Partners first reported a position in QGENF in Q2 2013 and held it in 7 quarters. The position peaked at $27.1M in Q2 2014. 175 funds tracked by Wall St. Rank hold QGENF as of Q1 2015.

Champlain Investment Partners reported no remaining QIAGEN NV position as of Q1 2015 after selling out during the quarter.
Champlain Investment Partners sold 562,705 QIAGEN NV shares in Q1 2015, an estimated $13.2M.
Champlain Investment Partners first reported a position in QIAGEN NV in Q2 2013 and held it in 7 quarters.
Champlain Investment Partners's QIAGEN NV position peaked at $27.1M in Q2 2014.
175 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2015.

Based on Champlain Investment Partners's 13F filing for Q1 2015, filed 13 May 2015.